טוען...
Adverse experiences with implantable defibrillators in Oregon hospices
BACKGROUND: Implantable cardioverter-defibrillators (ICDs) improve survival in patients at risk for recurrent, sustained ventricular tachycardia or fibrillation. Unless deactivated, ICDs may deliver unwanted shocks to terminally ill patients near the time of death. This study sought to determine the...
שמור ב:
Main Authors: | , , , |
---|---|
פורמט: | Artigo |
שפה: | Inglês |
יצא לאור: |
2010
|
נושאים: | |
גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3578584/ https://ncbi.nlm.nih.gov/pubmed/21112878 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1049909110390505 |
תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|